Global HER2 Antibodies Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Trastuzumab
1.3.3 Lapatinib
1.3.4 Ado-trastuzumab emtansine
1.3.5 Pertuzumab
1.3.6 Everolimus
1.4 Market by Application
1.4.1 Global HER2 Antibodies Market Share by Application: 2020 VS 2026
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 E-commerce
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HER2 Antibodies Market Perspective (2015-2026)
2.2 HER2 Antibodies Growth Trends by Regions
2.2.1 HER2 Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HER2 Antibodies Historic Market Share by Regions (2015-2020)
2.2.3 HER2 Antibodies Forecasted Market Size by Regions (2021-2026)
2.3 HER2 Antibodies Industry Dynamic
2.3.1 HER2 Antibodies Market Trends
2.3.2 HER2 Antibodies Market Drivers
2.3.3 HER2 Antibodies Market Challenges
2.3.4 HER2 Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibodies Players by Market Size
3.1.1 Global Top HER2 Antibodies Players by Revenue (2015-2020)
3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2015-2020)
3.2 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HER2 Antibodies Revenue
3.4 Global HER2 Antibodies Market Concentration Ratio
3.4.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2019
3.5 Key Players HER2 Antibodies Area Served
3.6 Key Players HER2 Antibodies Product Solution and Service
3.7 Date of Enter into HER2 Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HER2 Antibodies Breakdown Data by Type
4.1 Global HER2 Antibodies Historic Market Size by Type (2015-2020)
4.2 Global HER2 Antibodies Forecasted Market Size by Type (2021-2026)
5 HER2 Antibodies Breakdown Data by Application
5.1 Global HER2 Antibodies Historic Market Size by Application (2015-2020)
5.2 Global HER2 Antibodies Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HER2 Antibodies Market Size (2015-2026)
6.2 North America HER2 Antibodies Market Size by Type (2015-2020)
6.3 North America HER2 Antibodies Market Size by Application (2015-2020)
6.4 North America HER2 Antibodies Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe HER2 Antibodies Market Size (2015-2026)
7.2 Europe HER2 Antibodies Market Size by Type (2015-2020)
7.3 Europe HER2 Antibodies Market Size by Application (2015-2020)
7.4 Europe HER2 Antibodies Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HER2 Antibodies Market Size (2015-2026)
8.2 Asia-Pacific HER2 Antibodies Market Size by Type (2015-2020)
8.3 Asia-Pacific HER2 Antibodies Market Size by Application (2015-2020)
8.4 Asia-Pacific HER2 Antibodies Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America HER2 Antibodies Market Size (2015-2026)
9.2 Latin America HER2 Antibodies Market Size by Type (2015-2020)
9.3 Latin America HER2 Antibodies Market Size by Application (2015-2020)
9.4 Latin America HER2 Antibodies Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HER2 Antibodies Market Size (2015-2026)
10.2 Middle East & Africa HER2 Antibodies Market Size by Type (2015-2020)
10.3 Middle East & Africa HER2 Antibodies Market Size by Application (2015-2020)
10.4 Middle East & Africa HER2 Antibodies Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis HER2 Antibodies Introduction
11.1.4 Novartis Revenue in HER2 Antibodies Business (2015-2020))
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer HER2 Antibodies Introduction
11.2.4 Pfizer Revenue in HER2 Antibodies Business (2015-2020)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche HER2 Antibodies Introduction
11.3.4 Roche Revenue in HER2 Antibodies Business (2015-2020)
11.3.5 Roche Recent Development
11.4 Abnova
11.4.1 Abnova Company Details
11.4.2 Abnova Business Overview
11.4.3 Abnova HER2 Antibodies Introduction
11.4.4 Abnova Revenue in HER2 Antibodies Business (2015-2020)
11.4.5 Abnova Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Company Details
11.5.2 InvivoGen Business Overview
11.5.3 InvivoGen HER2 Antibodies Introduction
11.5.4 InvivoGen Revenue in HER2 Antibodies Business (2015-2020)
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Details
11.6.2 Celltrion Business Overview
11.6.3 Celltrion HER2 Antibodies Introduction
11.6.4 Celltrion Revenue in HER2 Antibodies Business (2015-2020)
11.6.5 Celltrion Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Biocon Business Overview
11.7.3 Biocon HER2 Antibodies Introduction
11.7.4 Biocon Revenue in HER2 Antibodies Business (2015-2020)
11.7.5 Biocon Recent Development
11.8 Novus Biologicals
11.8.1 Novus Biologicals Company Details
11.8.2 Novus Biologicals Business Overview
11.8.3 Novus Biologicals HER2 Antibodies Introduction
11.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2015-2020)
11.8.5 Novus Biologicals Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global HER2 Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Trastuzumab
Table 3. Key Players of Lapatinib
Table 4. Key Players of Ado-trastuzumab emtansine
Table 5. Key Players of Pertuzumab
Table 6. Key Players of Everolimus
Table 7. Global HER2 Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global HER2 Antibodies Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global HER2 Antibodies Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global HER2 Antibodies Market Share by Regions (2015-2020)
Table 11. Global HER2 Antibodies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global HER2 Antibodies Market Share by Regions (2021-2026)
Table 13. HER2 Antibodies Market Market Trends
Table 14. HER2 Antibodies Market Drivers
Table 15. HER2 Antibodies Market Challenges
Table 16. HER2 Antibodies Market Restraints
Table 17. Global HER2 Antibodies Revenue by Players (2015-2020) (US$ Million)
Table 18. Global HER2 Antibodies Market Share by Players (2015-2020)
Table 19. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2019)
Table 20. Global HER2 Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players HER2 Antibodies Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 25. Global HER2 Antibodies Revenue Market Share by Type (2015-2020)
Table 26. Global HER2 Antibodies Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 27. Global HER2 Antibodies Market Size Share by Application (2015-2020) (US$ Million)
Table 28. Global HER2 Antibodies Revenue Market Share by Application (2015-2020)
Table 29. Global HER2 Antibodies Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 30. North America HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 31. North America HER2 Antibodies Market Share by Type (2015-2020)
Table 32. North America HER2 Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 33. North America HER2 Antibodies Market Share by Application (2015-2020)
Table 34. North America HER2 Antibodies Market Size by Country (US$ Million) (2015-2020)
Table 35. North America HER2 Antibodies Market Share by Country (2015-2020)
Table 36. Europe HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe HER2 Antibodies Market Share by Type (2015-2020)
Table 38. Europe HER2 Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe HER2 Antibodies Market Share by Application (2015-2020)
Table 40. Europe HER2 Antibodies Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe HER2 Antibodies Market Share by Country (2015-2020)
Table 42. Asia-Pacific HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 43. Asia-Pacific HER2 Antibodies Market Share by Type (2015-2020)
Table 44. Asia-Pacific HER2 Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 45. Asia-Pacific HER2 Antibodies Market Share by Application (2015-2020)
Table 46. Asia-Pacific HER2 Antibodies Market Size by Region (US$ Million) (2015-2020)
Table 47. Asia-Pacific HER2 Antibodies Market Share by Region (2015-2020)
Table 48. Latin America HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 49. Latin America HER2 Antibodies Market Share by Type (2015-2020)
Table 50. Latin America HER2 Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 51. Latin America HER2 Antibodies Market Share by Application (2015-2020)
Table 52. Latin America HER2 Antibodies Market Size by Country (US$ Million) (2015-2020)
Table 53. Latin America HER2 Antibodies Market Share by Country (2015-2020)
Table 54. Middle East & Africa HER2 Antibodies Market Size by Type (2015-2020) (US$ Million)
Table 55. Middle East & Africa HER2 Antibodies Market Share by Type (2015-2020)
Table 56. Middle East & Africa HER2 Antibodies Market Size by Application (2015-2020) (US$ Million)
Table 57. Middle East & Africa HER2 Antibodies Market Share by Application (2015-2020)
Table 58. Middle East & Africa HER2 Antibodies Market Size by Country (US$ Million) (2015-2020)
Table 59. Middle East & Africa HER2 Antibodies Market Share by Country (2015-2020)
Table 60. Novartis Company Details
Table 61. Novartis Business Overview
Table 62. Novartis HER2 Antibodies Product
Table 63. Novartis Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 64. Novartis Recent Development
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer HER2 Antibodies Product
Table 68. Pfizer Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche HER2 Antibodies Product
Table 73. Roche Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 74. Roche Recent Development
Table 75. Abnova Company Details
Table 76. Abnova Business Overview
Table 77. Abnova HER2 Antibodies Product
Table 78. Abnova Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 79. Abnova Recent Development
Table 80. InvivoGen Company Details
Table 81. InvivoGen Business Overview
Table 82. InvivoGen HER2 Antibodies Product
Table 83. InvivoGen Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 84. InvivoGen Recent Development
Table 85. Celltrion Company Details
Table 86. Celltrion Business Overview
Table 87. Celltrion HER2 Antibodies Product
Table 88. Celltrion Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 89. Celltrion Recent Development
Table 90. Biocon Company Details
Table 91. Biocon Business Overview
Table 92. Biocon HER2 Antibodies Product
Table 93. Biocon Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 94. Biocon Recent Development
Table 95. Novus Biologicals Business Overview
Table 96. Novus Biologicals HER2 Antibodies Product
Table 97. Novus Biologicals Company Details
Table 98. Novus Biologicals Revenue in HER2 Antibodies Business (2015-2020) (US$ Million)
Table 99. Novus Biologicals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global HER2 Antibodies Market Share by Type: 2020 VS 2026
Figure 2. Trastuzumab Features
Figure 3. Lapatinib Features
Figure 4. Ado-trastuzumab emtansine Features
Figure 5. Pertuzumab Features
Figure 6. Everolimus Features
Figure 7. Global HER2 Antibodies Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. E-commerce Case Studies
Figure 11. HER2 Antibodies Report Years Considered
Figure 12. Global HER2 Antibodies Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global HER2 Antibodies Market Share by Regions: 2020 VS 2026
Figure 14. Global HER2 Antibodies Market Share by Regions (2021-2026)
Figure 15. Global HER2 Antibodies Market Share by Players in 2019
Figure 16. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by HER2 Antibodies Revenue in 2019
Figure 18. North America HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE HER2 Antibodies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Novartis Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 44. Pfizer Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 45. Roche Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 46. Abnova Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 47. InvivoGen Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 48. Celltrion Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 49. Biocon Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 50. Novus Biologicals Revenue Growth Rate in HER2 Antibodies Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed